OR WAIT 15 SECS
MELVILLE, N.Y. -- Bovie Medical Corporation, a manufacturer and marketer of electrosurgery products, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to commence manufacturing and marketing of the Bovie IDS-300 for use in general surgeries and other minimally invasive surgical procedures.
The high frequency generator features both monpolar and bipolar functions combined with 300 watts of cutting power. The Bovie IDS-300 was specifically designed for today's operating room and surgi-center market. Deliveries of the IDS-300 will commence during the first quarter of FY 2003, and are expected to contribute in excess of $2.0 million to Bovie's current fiscal year revenues.
The FDA clearance places Bovie in a solid position to maximize the reputation of the "Bovie" name in electrosurgery. Early demand for the Bovie IDS-300 watt generator, which is a fully-digital electrosurgical unit with many physician friendly features, indicates that FY 2003 will be one of increased sales and profitability. The company also announced that it expects to report increased revenues for FY 2002. Revenues for FY 2001 were $11.5 million.
Source: Bovie Medical Corporation